TMEM16A inhibitor CACCinh-A01 attenuated brain infarct size, improved neurological outcomes and lowered blood-brain barrier permeability after ischemic stroke in mice (Liu et al., 2019). The gene discussed is ANO1; the disease is brain infarction.